IMMUNOCLIN

USPTO USPTO 2000 CANCELLED - SECTION 8

Schützen Sie diese Marke vor Nachahmern!

Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.

Die US-Marke IMMUNOCLIN wurde als Wortmarke am 29.06.2000 beim Amerikanischen Patent- und Markenamt angemeldet.
Sie wurde am 03.01.2006 im Markenregister eingetragen. Der aktuelle Status der Marke ist "CANCELLED - SECTION 8".

Markendetails Letztes Update: 24. Mai 2018

Markenform Wortmarke
Aktenzeichen 76975136
Registernummer 3037460
Anmeldedatum 29. Juni 2000
Veröffentlichungsdatum 03. Juni 2003
Eintragungsdatum 03. Januar 2006

Markeninhaber

ROWLANDSON HOUSE
N12 8NP LONDON
GB

Markenvertreter

Waren und Dienstleistungen

1 CHEMICAL PREPARATIONS FOR TESTING BLOOD FOR SCIENTIFIC USE
5 Pharmaceutical preparations for use in the diagnosis and treatment of immune system deficiencies and diseases involving the immune system, namely, transplant rejection, rheumatoid arthritis, cancers, myalgic encephalomyelitis (ME), chronic fatigue syndrome (CFS) chronic fatigue and immune dysfunction syndrome (CFIDS), fibromyalgia syndrome (FMS), multiple sclerosis (MS), HIV/AIDs, hepatitis, and human papilloma virus; chemical preparations for testing blood for medical purposes and diagnostic and testing materials for medical use, namely, diagnostic reagents for clinical or medical laboratory use; vaccines and sera containing antibodies; pharmaceutical preparations for treatment of immune system deficiencies, namely, protein chips and/or biological assays such as enzyme-linked immunosorbent assay (ELISA)
41 Education services, namely, conducting face-to-face and on-line real-time classes, seminars, conferences and workshops among patients and physicians and providing information related thereto in the field of immunology and prevention and clinical management of diseases that require modulation of the immune systems, and distributing course materials in connection therewith; development and dissemination of educational materials of others in the field of immunology and prevention and clinical management of diseases that require modulation of the immune system
42 Performing a combination of predictive medical tests, compiling and presenting results of said tests by way of comparable numeric data where results data are presented in a graph against a background and rising scale of known values which enables immediate visual comparison and interpretation of individual test services results against existing data
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen

ID: 1376975136